The North America Unit Dose Manufacturing Market size is expected to reach USD 21.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.9% from 2021 to 2028. The rapidly growing pharmaceutical industry and rising demand for unit doses are factors driving the market.
Single-dose packaging has certainly become one of the
most popular recent trends. The most obvious benefit is its ease of use and
improved medication management, as they can be prescribed by the unit, ensuring
that the person taking it does not exceed the prescribed dose. Stick packs are
unique in the way that they can be used to package a variety of items, both dry
and wet.
Measuring cups, teaspoons, tablespoons, and
multi-dose containers for oral liquids and eye drops have been already seen.
The current patient is seeking convenience. Doctors are also appreciating the
importance of unit dose in prescription writing since it allows them to
prescribe controlled substance oral liquid without concern of abuse as unit
doses address the issue. It also enables pharmacists to store oral liquids in a
secure manner, which is a significant additional benefit. Nearly every single
unit dose oral solid or multiple-dose oral liquid could be transformed to a
unit dose oral liquid due to this innovation.
However, owing to the COVID-19 pandemic's
repercussions, the unit dose manufacturing market increased at a modest 11.0%
year over year in 2020. By the end of 2020, the market started to recover.
COVID-19-related illnesses are being treated using unit dosages. Hospitals have
updated and implemented various new standard operating procedures to protect
both patients and healthcare workers. As a consequence, it's crucial to
consider out viral transmission by airborne transmission or direct contact.
When unit dose medicines are used, some of the risks involved with handling and
pouring doses from the same bottle are reduced.
Related Press Release@ North America Unit Dose Manufacturing Market Report
North America Unit Dose
Manufacturing Market Report Highlights
- The outsourcing segment dominated the market and accounted for the
largest revenue share of 59.6% in 2020. Unit doses lead to the
minimization of credits for drugs coupled with greater control by a
pharmacist over work patterns and schedules
- The solid unit dose segment held 49.1% of the revenue share in
2020. In 2018, oral solid dosage medicines accounted for 53% of all new
pharmaceuticals approved by the FDA
- The independent pharmacies segment dominated the market and
accounted for the largest revenue share of 34.1% in 2020
- The hospital segment held the second-largest revenue share in 2020.
The segment is estimated to become 3.5 times of itself by 2028
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment